file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
Word(i) List (4568) Word count: 24159, All words count: 34321 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
201 | DETECTION | 23 | 77 | 688 |
202 | CUTANEOUS | 12 | 38 | 687 |
203 | HOMOGRAFTS | 13 | 339 | 686 |
204 | IMMUNITY | 23 | 228 | 680 |
205 | PATHWAYS | 5 | 43 | 678 |
206 | PROGENITOR | 6 | 47 | 678 |
207 | STATUS | 27 | 90 | 678 |
208 | NERVE | 20 | 84 | 675 |
209 | INJURY | 22 | 54 | 673 |
210 | DISTINCT | 3 | 32 | 672 |
211 | EFFICACY | 26 | 78 | 671 |
212 | REACTIVITY | 15 | 89 | 666 |
213 | BASIS | 7 | 582 | 659 |
214 | LUNG | 50 | 165 | 659 |
215 | SYSTEMIC | 19 | 235 | 657 |
216 | WEANING | 8 | 249 | 653 |
217 | AGENT | 17 | 48 | 652 |
218 | RISK-FACTORS | 7 | 62 | 627 |
219 | DOGS | 14 | 73 | 626 |
220 | SYNTHESIS | 16 | 47 | 626 |
221 | ACTIVATION | 17 | 57 | 615 |
222 | RELATED | 23 | 49 | 615 |
223 | ANTIBODY | 34 | 94 | 612 |
224 | IMPACT | 18 | 52 | 612 |
225 | DELETION | 5 | 161 | 607 |
226 | EVALUATION | 26 | 52 | 605 |
227 | XENOGENEIC | 11 | 24 | 601 |
228 | COMPARING | 9 | 71 | 597 |
229 | CIRCULATING | 12 | 28 | 596 |
230 | PERSIST | 2 | 30 | 593 |
# | Word | Recs | TLCS | TGCS |
231 | FORMED | 3 | 37 | 591 |
232 | FUNCTIONAL | 17 | 136 | 590 |
233 | HEPATITIS | 18 | 27 | 589 |
234 | POSTPARTUM | 1 | 29 | 585 |
235 | POTENTIAL | 15 | 63 | 584 |
236 | PORCINE | 9 | 21 | 583 |
237 | COMBINATION | 17 | 48 | 582 |
238 | LYMPHOCYTES-T | 2 | 34 | 582 |
239 | TRANSFUSION | 22 | 85 | 580 |
240 | RECEPTOR | 12 | 12 | 577 |
241 | STEROIDS | 23 | 116 | 576 |
242 | INFECTIOUS | 8 | 43 | 575 |
243 | BODY | 7 | 20 | 572 |
244 | UREMIA | 4 | 40 | 571 |
245 | VITRO | 20 | 63 | 571 |
246 | HETEROTRANSPLANTATION | 9 | 121 | 569 |
247 | ABDOMINAL | 6 | 76 | 560 |
248 | PROLIFERATION | 17 | 47 | 560 |
249 | RISK | 16 | 25 | 560 |
250 | HYPERTENSION | 14 | 19 | 553 |
251 | INHIBITED | 1 | 30 | 552 |
252 | CYTOTOXIC | 9 | 139 | 545 |
253 | HOST | 28 | 77 | 544 |
254 | INDUCES | 6 | 18 | 544 |
255 | CYCLOSPORINE-TREATED | 8 | 69 | 538 |
256 | PIG | 6 | 9 | 536 |
257 | STEM | 27 | 89 | 536 |
258 | DONOR-DERIVED | 24 | 173 | 535 |
259 | IMMUNOLOGICAL | 34 | 69 | 535 |
260 | CYTOKINE | 18 | 79 | 532 |
# | Word | Recs | TLCS | TGCS |
261 | DOSE | 20 | 66 | 529 |
262 | FUTURE | 32 | 41 | 523 |
263 | PARTICULAR | 16 | 184 | 523 |
264 | UREMIC | 9 | 25 | 522 |
265 | ENDOGENOUS | 4 | 5 | 521 |
266 | INDUCE | 15 | 94 | 521 |
267 | RESPONSE | 33 | 122 | 519 |
268 | LEVELS | 18 | 77 | 517 |
269 | INFUSION | 22 | 172 | 509 |
270 | LIVING-RELATED | 16 | 89 | 507 |
271 | COLONY-STIMULATING | 4 | 162 | 505 |
272 | RESPONSES | 29 | 97 | 501 |
273 | AUGMENTATION | 14 | 257 | 497 |
274 | MIGRATION | 22 | 247 | 497 |
275 | POSTTRANSPLANT | 15 | 67 | 495 |
276 | MONOTHERAPY | 18 | 75 | 491 |
277 | REPORT | 21 | 80 | 491 |
278 | RETROVIRUS | 2 | 4 | 486 |
279 | SEARCH | 3 | 4 | 486 |
280 | ADMINISTRATION | 28 | 66 | 483 |
281 | ANTILYMPHOID | 6 | 436 | 480 |
282 | XENOTRANSPLANTATION | 28 | 60 | 480 |
283 | FEATURES | 9 | 23 | 479 |
284 | PROLONG | 7 | 89 | 478 |
285 | FACTOR | 9 | 125 | 476 |
286 | RESCUE | 21 | 149 | 476 |
287 | CROSS-SPECIES | 1 | 4 | 475 |
288 | FTY720 | 4 | 9 | 474 |
289 | IMPLICATIONS | 16 | 134 | 472 |
290 | SUCCESSFUL | 19 | 110 | 467 |
# | Word | Recs | TLCS | TGCS |
291 | DEATH | 11 | 39 | 466 |
292 | SERA | 19 | 101 | 466 |
293 | COMPOSITE | 28 | 82 | 461 |
294 | LEARNED | 7 | 34 | 461 |
295 | STABLE | 7 | 24 | 461 |
296 | LEUKOCYTES | 22 | 197 | 459 |
297 | IDENTIFICATION | 16 | 59 | 454 |
298 | SOLID | 29 | 113 | 454 |
299 | MOUSE | 16 | 96 | 452 |
300 | REPLACEMENT | 10 | 32 | 450 |
301 | MASS-SPECTROMETRY | 3 | 3 | 447 |
302 | ANTI-LYMPHOCYTE | 17 | 68 | 445 |
303 | DIM | 2 | 81 | 445 |
304 | CD8 | 9 | 38 | 444 |
305 | BABOON | 4 | 142 | 443 |
306 | INCREASES | 7 | 57 | 443 |
307 | SELECTIVELY | 5 | 11 | 443 |
308 | TOXICITY | 11 | 37 | 443 |
309 | CONVERSION | 14 | 156 | 441 |
310 | PRETREATMENT | 16 | 110 | 440 |
311 | ORIGIN | 13 | 27 | 439 |
312 | INSTITUTION | 2 | 24 | 435 |
313 | RESPONSIBLE | 5 | 45 | 434 |
314 | PATHOGENESIS | 10 | 14 | 431 |
315 | SINGLE-CENTER | 12 | 55 | 430 |
316 | SUBLETHAL | 4 | 14 | 429 |
317 | HEPATOCELLULAR-CARCINOMA | 1 | 1 | 428 |
318 | RESECTION | 1 | 1 | 428 |
319 | LIVER-DISEASE | 3 | 11 | 427 |
320 | MATCHING | 10 | 112 | 426 |
# | Word | Recs | TLCS | TGCS |
321 | MATURE | 3 | 20 | 426 |
322 | GRAFT-SURVIVAL | 7 | 41 | 423 |
323 | INTERACTIONS | 8 | 27 | 422 |
324 | UROLOGICAL | 5 | 24 | 421 |
325 | INVITRO | 18 | 37 | 419 |
326 | THYMUS | 17 | 45 | 419 |
327 | CENTER | 7 | 33 | 418 |
328 | IMMUNOSUPPRESSED | 8 | 12 | 418 |
329 | ENZYMES | 3 | 42 | 416 |
330 | NONCOVALENT | 2 | 0 | 412 |
331 | RENAL-HOMOGRAFT | 2 | 30 | 412 |
332 | CHARACTERIZATION | 13 | 69 | 411 |
333 | DLA-IDENTICAL | 1 | 13 | 410 |
334 | HEPATITIS-B | 1 | 6 | 410 |
335 | LITTERMATE | 1 | 13 | 410 |
336 | PROLONGATION | 21 | 79 | 410 |
337 | RATE | 6 | 52 | 409 |
338 | TARGETS | 4 | 7 | 409 |
339 | AUTOIMMUNE | 18 | 20 | 408 |
340 | HOMING | 2 | 40 | 405 |
341 | KIDNEY-TRANSPLANT | 5 | 77 | 405 |
342 | LESSONS | 9 | 33 | 405 |
343 | MAJOR | 14 | 46 | 404 |
344 | RENAL-FUNCTION | 9 | 123 | 404 |
345 | IN-VITRO | 15 | 63 | 403 |
346 | REGULATION | 15 | 51 | 402 |
347 | SUBSEQUENT | 5 | 313 | 402 |
348 | BILIARY | 7 | 37 | 401 |
349 | DECREASES | 3 | 10 | 401 |
350 | HISTOCOMPATIBILITY | 19 | 92 | 401 |
# | Word | Recs | TLCS | TGCS |
351 | INFLUENCE | 28 | 58 | 401 |
352 | RISKS | 5 | 21 | 399 |
353 | CLONAL | 5 | 68 | 397 |
354 | HYPORESPONSIVENESS | 10 | 56 | 397 |
355 | METABOLITES | 6 | 59 | 397 |
356 | PANCREATIC | 9 | 64 | 397 |
357 | MELLITUS | 11 | 12 | 396 |
358 | ENDOTHELIAL | 8 | 28 | 394 |
359 | NATURAL | 21 | 50 | 394 |
360 | APOPTOSIS | 13 | 85 | 393 |
361 | PANCREATIC-ISLET | 4 | 28 | 393 |
362 | DIABETES-MELLITUS | 9 | 35 | 392 |
363 | STEROID | 14 | 45 | 392 |
364 | HEMODIALYSIS | 13 | 10 | 391 |
365 | RESPONSIVENESS | 1 | 14 | 391 |
366 | INSULIN | 9 | 55 | 388 |
367 | REACTIONS | 11 | 140 | 385 |
368 | OUTCOMES | 11 | 47 | 383 |
369 | LOW-DOSE | 13 | 60 | 381 |
370 | ANTIGEN-SPECIFIC | 4 | 39 | 380 |
371 | COMPARATIVE | 10 | 39 | 380 |
372 | HYPERPLASIA | 6 | 42 | 378 |
373 | THYMOGLOBULIN | 8 | 59 | 376 |
374 | ROTAMASE | 3 | 16 | 375 |
375 | VASCULAR | 13 | 22 | 374 |
376 | MULTICENTER | 10 | 55 | 371 |
377 | HIGH | 9 | 32 | 369 |
378 | TYPE-1 | 2 | 150 | 369 |
379 | ANTILYMPHOCYTIC | 17 | 68 | 368 |
380 | STRATEGIES | 20 | 29 | 368 |
# | Word | Recs | TLCS | TGCS |
381 | PRESENT | 14 | 36 | 366 |
382 | LIVERS | 5 | 181 | 365 |
383 | IN-VIVO | 10 | 16 | 364 |
384 | LOCAL | 8 | 23 | 364 |
385 | NUMBER | 3 | 8 | 363 |
386 | INTERLEUKIN-10 | 5 | 6 | 362 |
387 | LYMPHOID | 15 | 111 | 362 |
388 | STEROID-THERAPY | 3 | 56 | 362 |
389 | FAILURE | 21 | 14 | 361 |
390 | ACCELERATION | 1 | 8 | 359 |
391 | ANTI-THYMOCYTE | 10 | 70 | 359 |
392 | SEQUESTRATION | 1 | 8 | 359 |
393 | SYNDROME | 14 | 45 | 357 |
394 | ISCHEMIA | 11 | 20 | 356 |
395 | PROLINE | 4 | 6 | 354 |
396 | FOLLOW-UP | 22 | 54 | 353 |
397 | DELETERIOUS | 3 | 3 | 352 |
398 | TRANSPLANTATIONS | 6 | 46 | 352 |
399 | ASPECTS | 27 | 46 | 348 |
400 | DISEASES | 11 | 22 | 345 |